View original stored description
Republic of the Philippines
Province of Davao Oriental
City of Mati
BIDS & AWARDS COMMITTEE
INVITATION TO BID
LOT Supply and Delivery of DRUGS AND MEDICINES (All-in One Admixtures 1400 kcal, etc.) for the use of Out Patient Department, Emergency Department, and Admitted Patients of DOPMC
SOURCE OF FUND: General Fund [5-02-03-070]
1. The Provincial Government of Davao Oriental through the Bids and Awards Committee (BAC) intends to apply the sum of THIRTEEN MILLION SIX HUNDRED SIXTY-NINE THOUSAND FIVE HUNDRED TWENTY-SIX PESOS (Php13,669,526.00) being the Approved Budget for Contract (ABC) payments under the contract for the LOT Supply and Delivery of DRUGS AND MEDICINES (All-in One Admixtures 1400 kcal, etc.) for the use of Out Patient Department, Emergency Department, and Admitted Patients of DOPMC. Bids received in excess of the ABC shall be automatically rejected at Bid opening.
2. The Provincial Government of Davao Oriental now invites bids for the LOT Supply and Delivery of DRUGS AND MEDICINES (All-in One Admixtures 1400 kcal, etc.) for the use of Out Patient Department, Emergency Department, and Admitted Patients of DOPMC. Delivery of the goods is within 30 Calendar days. Bidders should have completed, within 2 years from the date of submission and receipt of bids, a contract similar to the Project. The description of an eligible bidder is contained in the Bidding Documents, particularly in Section II- Instruction to Bidders.
3. Bidding will be conducted through open competitive bidding procedures using non-discretionary pass/fail criterion as specified in the Implementing Rules and Regulations (IRR) of Republic Act 12009 (R.A. 12009), otherwise known as the “New Government Procurement Reform Act”.
4. Interested Bidders may obtain further information from BAC Secretariat and inspect the bidding documents at the address given below during office hours.
5. A complete set of Bidding Documents may be purchased by interested bidders on October 26 – November 16, 2026 from the address below and upon payment of a non-refundable fee for the Bidding Documents in the amount of TWENTY-FIVE THOUSAND PESOS (Php25,000.00).
6. The Provincial Government of Davao Oriental thru its BAC will hold a Pre-Bid Conference on November 3, 2026 at 2:00pm at the Bids and Awards Committee (BAC) Conference Room, Provincial Capitol Mansion, Capitol Hill, City of Mati, Davao Oriental.
7. Bids must be delivered to the address below on or before November 17, 2026 - 2:00pm. All bids must be accompanied by a Bid Security in any of the acceptable forms and in the amount stated in ITB Clause 18.
Form of Bid Security - Cash or cashier’s/manager’s check issued by a Universal or Commercial Bank (2% of ABC)
Minimum Amount - Php273,390.52
Form of Bid Security - Bank draft/guarantee or irrevocable letter of credit issued by a Universal or Commercial Bank. Provided, however, that it shall be confirmed or authenticated by a Universal or Commercial Bank, if issued by a foreign bank ( 5% of ABC)
Minimum Amount - Php683,476.30
Form of Bid Security - Surety Bond callable upon demand issued by a surety or insurance company duly certified by the Insurance Commission as authorized to issue such security (5% of ABC)
Minimum Amount - Php683,476.30
Form of Bid Security - Bid Securing Declaration
8. Bid opening shall be on November 17, 2026 - 2:00pm at the BAC Conference Room, Capitol Hill, City of Mati. Bids will be opened in the presence of the Bidders or their representatives who choose to attend. Late bids shall not be accepted.
9. The Provincial Government of Davao Oriental reserves the right to accept or reject any Bid, to annul the bidding process, and to reject all Bids at any time prior to contract award, without thereby incurring any liability to the affected Bidder or Bidders.
10. For further information, please refer to:
ENGR. GISICA Y. SAYMANs
Head, BAC Secretariat
Provincial Capitol Mansion, Capitol Hill
City of Mati, Davao Oriental
Tel. No.: (087) 3883-353
Approved:
ATTY. ARMAND B. DIOSO
BAC Chairman
Other Information
1. 135 bag ALL-IN-ONE ADMIXTURES 1400 kcal
2. 250 Vial/Ampule ANTI-RABIES SERUM (equine) 200 IU/5 mL, vial
3. 3,000 Ampule ANTI-TETANUS SERUM (EQUINE) 1,500 IU/0.7 mL, ampule
4. 30 Vial AZITHROMYCIN 500 mg vial
5. 350 Vial BCG Vaccine 500 mcg/mL vial + 1 mL diluent in ampule 20 doses
6. 55 Vial BIPHASIC ISOPHANE HUMAN INSULIN 70/30 (RECOMBINANT DNA) 70% isophane suspension + 30% soluble insulin in: 100 IU/mL suspension for injection, 10 mL vial
7. 200 Ampule BUPIVACAINE (isobaric) 0.5% (as hydrochloride) , 5 mL ampule
8. 700 Ampule BUPIVACAINE (spinal) 0.5% (as hydrochloride), 4 mL with 8% dextrose individually packed ampule
9. 60 Ampule CARBETOCIN 100 mcg/mL, 1 mL ampule
10. 350 Ampule CARBOPROST 125 mcg/0.5 mL solution ampule
11. 2,000 Vial CEFOXITIN 1 g (as sodium salt), vial
12. 900 PFS ENOXAPARIN 100 mg/mL, 0.4 mL pre-filled syringe (as sodium salt)
13. 1,800 Ampule EPINEPHRINE 1 mg/mL (as hydrochloride), 1 mL ampule
14. 300 PFS EPOETIN ALFA (RECOMBINANT HUMAN ERYTHROPOIETIN) 4,000 IU/0.4 mL, pre-filled syringe
15. 60 Vial HEPATITIS B IMMUNOGLOBULIN (HUMAN) 100 IU 0.5mL, vial
16. 60 Vial HEPATITIS B VACCINE (RECOMBINANT DNA) 20 mcg/mL monodose vial (IM) adult
17. 490 Bottle HUMAN ALBUMIN 20%, 50 mL bottle
18. 1,300 PFS/vial HUMAN TETANUS IMMUNOGLOBULIN 250 IU/mL 1 mL PFS/Vial
19. 180 Bag Hydroxyethyl Starch 6%, 500 mL Solution for Injection
20. 80 Bag Hypertonic Lactate 250 mL Solution for Injection Bag
21. 55 PFS INFLUENZA POLYVALENT VACCINE 0.5 mL suspension in a pre-filled syringe.
22. 180 Vial IOPAMIDOL 612 mg/mL equivalent to 300 mg iodine, 50 mL vial
23. 180 Vial IOPAMIDOL 612 mg/mL equivalent to 300 mg iodine, 100 mL vial
24. 300 Nebule IPRATROPIUM 250 mcg/mL (as bromide), 2 mL
25. 1,500 Vial MEROPENEM 1 g vial (as trihydrate)
26. 300 Vial MEROPENEM 500 mg vial (as trihydrate)
27. 1,700 Vial PIPERACILLIN + TAZOBACTAM 2 g + 250 mg (as sodium salt) vial
28. 6,638 Vial PIPERACILLIN + TAZOBACTAM 4 g + 500 mg (as sodium salt) vial
29. 6 Vial PURIFIED PROTEIN DERIVATIVE (PPD)TUBERCULIN 5 TU/0.1 mL, freeze-dried powder, vial + 2 mL diluent ampule (ID)
30. 300 Vial RABIES VACCINE, Vero Cell (purified) lyophilized powder, 2.5 IU/ 0.5 mL, vial + diluent (ID, IM)
31. 3,500 Ampule TETANUS TOXOID 40 IU/0.5 mL, 0.5 mL Ampule
32. 100 Vial VANCOMYCIN 500 mg vial (as hydrochloride)
33. 200 Vial VANCOMYCIN 1 g vial (as hydrochloride)
TERMS AND CONDITIONS:
1. Supplier is required to present/submit a valid certificate of product registration authorizing the registrant's marketing authority for said health product, pursuant to the License to Operate( LTO) issued by the Food and Drug Administration (FDA).
2. The supplier shall submit a valid FDA Lot Release Certificate for each applicable lot/batch, in accordance with FDA Advisory No. 2021-2037 and Administrative Order (AO) No. 47-A, s. 2001, for vaccines, toxoids, and immunoglobulins, specifically for Item Nos. 2, 3, 5, 15, 16, 18, 21, 30, and 31. The certificate shall be a condition for acceptance of the delivery.
3. The supplier shall comply with the specified packaging requirement for Item No. 8, which shall be individually packed.
4. Pharmaceutical products must have a shelf life of twenty-four (24) months. However, deliveries with a minimum remaining shelf life of twelve (12) months from the date of delivery shall be accepted. Expired items shall be replaced by the supplier up to the twenty-fourth (24th) month of shelf life, based on the date of first delivery.
5. Pharmaceutical products for delivery shall be packed, handled, and stored in such a manner that prevents bacterial contamination, mix-ups, and cross-contamination, particularly for IV antibiotics, anesthetic/emergency drugs, and other biological preparations.
6. During transit, appropriate temperature and relative humidity conditions shall be maintained for thermolabile products and other pharmaceutical items requiring cold chain management.
7. When using dry ice in containers, special care must be observed to ensure that pharmaceutical products do not come into direct contact with the dry ice, as this may adversely affect product quality( e.g. by freezing).
8. For conformity with the items requested, bidders must specify in their price quotations the packaging content, product strength and preparation of the product for proper bid evaluation.
9. For traceability purposes of certain pharmaceutical products delivered, the supplier shall issue a charge invoice/delivery receipt indicating the expiry date and lot/batch number of each item.
10. In case of an adverse drug reaction report, samples for assay (FDA) shall be obtained from the remaining stocks. The bidder shall replace the unused quantity accordingly.
11. All outside packaging/boxes of pharmaceutical products for delivery shall be properly labeled for easier and faster identification. Labels shall include the product name, expiry date, lot/batch number, special storage conditions, and handling precautions.
12. The goods shall be delivered progressively within 30 days, commencing 7 days from receipt of Purchase Order at DOPMC Pharmacy.
13. LOT BID
14. Any product found to have quality issues shall be replaced by the supplier at no additional cost to the procuring entity.
15. All items shall be subject to inspection and acceptance by the end - user.
Created by
ATTY. ARMAND B DIOSO
Date Created
26/10/2026
The PhilGEPS team is not responsible for any typographical errors or misinformation presented in the system. PhilGEPS only displays information provided for by its clients, and any queries regarding the postings should be directed to the contact person/s of the concerned party.
© 2004-2026 DBM Procurement Service. All rights reserved.
Help
|
Contact Us
|
Sitemap
New notices are collected periodically, but this service does not routinely refresh already-known notices. Stored dates and status may miss deadline extensions, cancellations, or amendments. Always check the latest official PhilGEPS notice. First-saved and last-update times describe our stored record, not a fresh check of the official notice.
BidAssistant PH is an independent discovery and screening aid, not PhilGEPS or a procuring agency.